100 related articles for article (PubMed ID: 16182296)
1. Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):870-3. PubMed ID: 16182296
[TBL] [Abstract][Full Text] [Related]
2. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
[TBL] [Abstract][Full Text] [Related]
3. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
4. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model.
Ruan LP; Chen S; Yu BY; Zhu DN; Cordell GA; Qiu SX
Eur J Med Chem; 2006 May; 41(5):605-10. PubMed ID: 16546303
[TBL] [Abstract][Full Text] [Related]
5. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
[TBL] [Abstract][Full Text] [Related]
6. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity.
Zhao L; Fang L; Xu Y; Zhao Y; He Z
Int J Pharm; 2008 Mar; 352(1-2):92-103. PubMed ID: 18053661
[TBL] [Abstract][Full Text] [Related]
7. Assessment of intestinal absorption of vitexin-2''-o-rhamnoside in hawthorn leaves flavonoids in rat using in situ and in vitro absorption models.
Xu YA; Fan G; Gao S; Hong Z
Drug Dev Ind Pharm; 2008 Feb; 34(2):164-70. PubMed ID: 18302035
[TBL] [Abstract][Full Text] [Related]
8. Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
Higaki K; Yata T; Sone M; Ogawara K; Kimura T
Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):231-40. PubMed ID: 11758652
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of penetrants with differing lipophilicities using O-acylmenthol derivatives as penetration enhancers.
Zhao L; Fang L; Xu Y; Liu S; He Z; Zhao Y
Eur J Pharm Biopharm; 2008 May; 69(1):199-213. PubMed ID: 18065216
[TBL] [Abstract][Full Text] [Related]
10. Absorption-Enhancing Effects of Bile Salts.
Moghimipour E; Ameri A; Handali S
Molecules; 2015 Aug; 20(8):14451-73. PubMed ID: 26266402
[TBL] [Abstract][Full Text] [Related]
11. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
Franco M; Lopedota A; Trapani A; Cutrignelli A; Meleleo D; Micelli S; Trapani G
Int J Pharm; 2008 Mar; 352(1-2):182-8. PubMed ID: 18055143
[TBL] [Abstract][Full Text] [Related]
12. Analytical method for monitoring concentrations of cyclosporin and lovastatin in vitro in an everted rat intestinal sac absorption model.
Sharma P; Chawla H; Panchagnula R
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Mar; 768(2):349-59. PubMed ID: 11888063
[TBL] [Abstract][Full Text] [Related]
13. Effects of bile salts on intestinal fatty acid absorption and esterification in the rat.
Clark M; Senior J
Gut; 1968 Dec; 9(6):731. PubMed ID: 5717995
[No Abstract] [Full Text] [Related]
14. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
Dahan A; Hoffman A
Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
[TBL] [Abstract][Full Text] [Related]
15. Further studies using carbamate esters as model compounds to investigate the role of lipophilicity in the gastrointestinal absorption of foreign compounds.
Houston JB; Upshall DG; Bridges JW
J Pharmacol Exp Ther; 1975 Oct; 195(1):67-72. PubMed ID: 1181405
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
[TBL] [Abstract][Full Text] [Related]
17. Ion pairing with bile salts modulates intestinal permeability and contributes to food-drug interaction of BCS class III compound trospium chloride.
Heinen CA; Reuss S; Amidon GL; Langguth P
Mol Pharm; 2013 Nov; 10(11):3989-96. PubMed ID: 23750707
[TBL] [Abstract][Full Text] [Related]
18. Bile salts and their importance for drug absorption.
Holm R; Müllertz A; Mu H
Int J Pharm; 2013 Aug; 453(1):44-55. PubMed ID: 23598075
[TBL] [Abstract][Full Text] [Related]
19. New propanoyloxy derivatives of 5β-cholan-24-oic acid as drug absorption modifiers.
Coufalová L; Mrózek L; Rárová L; Plaček L; Opatřilová R; Dohnal J; Král'ová K; Paleta O; Král V; Drašar P; Jampílek J
Steroids; 2013 May; 78(5):435-53. PubMed ID: 23435200
[TBL] [Abstract][Full Text] [Related]
20. Role of bile in pathogenesis of indomethacin-induced enteropathy.
Jacob M; Foster R; Sigthorsson G; Simpson R; Bjarnason I
Arch Toxicol; 2007 Apr; 81(4):291-8. PubMed ID: 17151867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
